CIAM
BEAM icon

Caitong International Asset Management’s Beam Therapeutics BEAM Stock Holding History

Caitong International Asset Management’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$356K Sell
10,377
-5,463
-34% -$165K 0.05% 293
2026
Q1 		$377K Buy
+15,840
New +$440K 0.07% 239
2025
Q2 		– Sell
-4,430
Closed -$86.5K – 2011
2025
Q1 		$86.5K Buy
+4,430
New +$116K 0.06% 323

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Caitong International Asset Management's BEAM Position: Q2 2026 in Review

Caitong International Asset Management reduced its Beam Therapeutics (BEAM) stake by 34% in Q2 2026, selling an estimated $165K and leaving 10,377 shares worth $356K. The position accounts for 0.05% of the portfolio, ranked #293.

Caitong International Asset Management first reported a position in BEAM in Q1 2025 and has held it in 3 quarters since. The position peaked at $377K in Q1 2026. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Caitong International Asset Management held 10,377 shares of Beam Therapeutics worth $356K as of Q2 2026.
  • Caitong International Asset Management sold 5,463 Beam Therapeutics shares in Q2 2026, an estimated $165K.
  • Beam Therapeutics made up 0.05% of Caitong International Asset Management's portfolio in Q2 2026, its #293 holding.
  • Caitong International Asset Management first reported a position in Beam Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • Caitong International Asset Management's Beam Therapeutics position peaked at $377K in Q1 2026.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.